David Nicholas Castledea, Director at MGC Pharmaceuticals, holds 3.19M shares in MGC Pharmaceuticals (Ticker: MGCLF). Most recently, David Nicholas Castledea Sold $1,500,000 shares of MGC Pharmaceuticals on May 27, 2016 for an estimated value of 85.80K.